EWTXEdgewise Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Edgewise Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EWTX본 종목 | $4.1B#7 | — | 9.1x#9 | — | — | -25.4%#10 | — | -0.0%#4 | -50.9%#7 | — | 109.8%#6 | — |
| COGT | $5.4B#1 | — | 10.1x#10 | 685.0x#10 | -65.0%#10 | -28.6%#11 | -4235.3%#10 | -61.8%#14 | -84.3%#8 | — | — | — |
| ERAS | $5.1B#2 | — | 14.2x#11 | — | — | 23.0%#6 | — | -34.4%#12 | — | — | 516.4%#1 | — |
| AMRN | — | — | — | — | -6.5%#8 | 55.4%#4 | -23.5%#5 | -8.7%#6 | -16.9%#4 | — | -23.0%#11 | — |
| DNTH | $4.6B#4 | — | 4.0x#7 | 2274.9x#11 | -67.3%#11 | -91.1%#14 | -8739.3%#12 | -13.9%#9 | — | — | 143.2%#3 | — |
| TVTX | $4.8B#3 | — | 210.4x#14 | 9.7x#3 | 110.5%#3 | 92.1%#1 | -12.8%#4 | -113.1%#15 | — | — | 43.3%#8 | — |
| GOSS | $4.4B#5 | — | — | 91.0x#8 | -57.7%#9 | -201.4%#15 | -352.2%#9 | — | — | — | -95.3%#13 | — |
| GPCR | $4.4B#6 | — | 3.2x#4 | — | — | -15.2%#9 | — | -10.4%#8 | — | — | -37.7%#12 | — |
| ARQT | $4.0B#8 | 145.5x#4 | 18.2x#12 | 10.7x#4 | 91.3%#4 | 88.5%#2 | -3.3%#3 | -7.3%#5 | -4.1%#3 | — | 29.3%#9 | — |
| TNGX | $3.9B#9 | — | 3.8x#6 | 62.7x#7 | 48.3%#5 | 22.0%#7 | -178.4%#7 | -9.9%#7 | — | — | 189.2%#2 | — |
| LQDA | $3.8B#10 | 30.1x#3 | 19.4x#13 | 23.9x#5 | 1031.2%#1 | 47.1%#5 | -32.5%#6 | -35.3%#13 | — | — | 67.1%#7 | — |
| ABCL | $3.7B#11 | — | 4.2x#8 | 49.7x#6 | 160.6%#2 | 10.1%#8 | -289.0%#8 | -16.3%#10 | -28.0%#5 | — | 127.1%#4 | — |
| XENE | $3.7B#12 | — | 3.0x#2 | 493.8x#9 | — | -47.6%#12 | -4974.3%#11 | -27.8%#11 | -32.5%#6 | — | — | — |
| OGN | $3.6B#13 | 17.7x#2 | 3.0x#3 | 0.6x#1 | -2.9%#7 | -78.4%#13 | 14.9%#1 | 15.7%#2 | 4.9%#2 | 5#1 | 111.6%#5 | 2.4%#1 |
| PBLS | $3.6B#14 | — | 3.4x#5 | — | — | — | — | 0.0%#3 | — | — | — | — |
| ACAD | $3.5B#15 | 9.2x#1 | 2.7x#1 | 3.3x#2 | 11.9%#6 | 73.0%#3 | 9.8%#2 | 29.9%#1 | 11.4%#1 | — | -8.0%#10 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice